Xu H, Greengard P, Gandy S
Department of Neurology and Neuroscience, Cornell University Medical College, New York, New York 10021, USA.
J Biol Chem. 1995 Oct 6;270(40):23243-5. doi: 10.1074/jbc.270.40.23243.
Phorbol esters, activators of protein kinase C (PKC), regulate the relative utilization of alternative processing pathways for the Alzheimer beta-amyloid precursor protein (beta-APP) in intact cells, increasing the production of nonamyloidogenic soluble beta-APP (s beta-APP) and decreasing that of neurotoxic beta-amyloid (A beta) peptide. The molecular and cellular bases of PKC-regulated beta-APP cleavage are poorly understood. Here we demonstrate in a reconstituted cell-free system that activation of endogenous PKC increases formation from the trans-Golgi network of secretory vesicles containing beta-APP and that this effect can be mimicked by purified PKC. The results demonstrate directly that PKC is involved in regulation of secretory vesicle formation and provide a mechanism by which PKC may reduce the formation of the A beta peptide characteristic of Alzheimer disease.
佛波酯是蛋白激酶C(PKC)的激活剂,可调节完整细胞中阿尔茨海默病β-淀粉样前体蛋白(β-APP)替代加工途径的相对利用,增加非淀粉样生成性可溶性β-APP(sβ-APP)的产生,并减少神经毒性β-淀粉样蛋白(Aβ)肽的产生。PKC调节β-APP裂解的分子和细胞基础尚不清楚。在这里,我们在一个重构的无细胞系统中证明,内源性PKC的激活增加了含有β-APP的分泌囊泡从反式高尔基体网络的形成,并且这种效应可以被纯化的PKC模拟。结果直接证明PKC参与分泌囊泡形成的调节,并提供了一种机制,通过该机制PKC可能减少阿尔茨海默病特征性Aβ肽的形成。